C. Rodríguez

发表

Amplification of the BRCA2 Pathway Gene EMSY in Sporadic Breast Cancer Is Related to Negative Outcome

Luke Hughes-Davies, Charles Theillet, Tony Kouzarides, 2004, Clinical Cancer Research.

Genomic and Expression Profiling of Chromosome 17 in Breast Cancer Reveals Complex Patterns of Alterations and Novel Candidate Genes

R. Redon, C. Nguyen, C. Theillet, 2004, Cancer Research.

A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study

A. Hénaut, J. Darbon, C. Theillet, 2007, BMC Cancer.

Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q

C. Nguyen, C. Theillet, N. Cervera, 2006, British Journal of Cancer.

Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene

C. Sardet, C. Theillet, C. Rodríguez, 2006, Proceedings of the National Academy of Sciences.

Molecular analysis of the IL‐6 receptor in human multiple myeloma, an IL‐6‐related disease

B. Klein, R. Bataille, C. Theillet, 1994, FEBS letters.

CD44 expression patterns in breast and colon tumors: A pcr‐based study of splice variants

B. Dutrillaux, P. Rouanet, C. Theillet, 1995, International journal of cancer.

A Novel Role for the Tumor Suppressor Gene ITF2 in Tumorigenesis and Chemotherapy Response

C. Rodríguez, P. Santisteban, C. Rodríguez-Antolín, 2020, Cancers.

Complex regulation of LCoR signaling in breast cancer cells

C. Rodríguez, A. Lucas, N. Elarouci, 2017, Oncogene.

At least five regions of imbalance on 6q in breast tumors, combining losses and gains

A. Causse, C. Theillet, C. Rodríguez, 2000, Genes, chromosomes & cancer.

Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells

L. M. Valor, G. Jiménez-Gómez, F. Mora-López, 2020, Scientific Reports.

Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer

M. Ehrlich, E. Fiala, C. Rodríguez, 2005, Genes, chromosomes & cancer.

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

J. Bergh, M. Olivier, P. Hainaut, 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification

C. Theillet, C. Rodríguez, B. Orsetti, 1999, Oncogene.

Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.

R. Zeillinger, P. Speiser, C. Theillet, 1997, Cancer research.

Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors

J. Bockaert, C. Theillet, A. Mazumdar, 1999, Oncogene.

DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.

R. Zeillinger, M. Tanner, P. Speiser, 1996, British Journal of Cancer.

Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases

A. Causse, C. Theillet, C. Rodríguez, 2002, Genes, chromosomes & cancer.

A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors

J. Duffour, P. Roepman, A. Duval, 2021, Cancers.

Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5

M. Gallas, R. Landgraf, X. Liu, 2012, Oncogene.

Truncated p 110 ERBB 2 induces mammary epithelial cell migration , invasion and orthotopic xenograft formation , and is associated with loss of phosphorylated STAT 5

M. Gallas, R. Landgraf, X. Liu, 2012 .

A novel role for the tumor suppressor geneITF2in lung tumorigenesis and chemotherapy response

C. Rodríguez, P. Santisteban, C. Rodríguez-Antolín, 2020 .

A novel role for the tumor suppressor gene ITF2 in lung tumorigenesis through the action of Wnt signaling pathway

C. Rodríguez, P. Santisteban, C. Rodríguez-Antolín, 2019, bioRxiv.

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.

K. Bystricky, T. Maudelonde, P. Blache, 2016, Oncotarget.

Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer.

C. Bascoul-Mollevi, C. Theillet, C. Rodríguez, 2011, The American journal of pathology.

CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus.

J. Piette, C. Rodríguez, G. Cathala, 2010, Biochemical and biophysical research communications.

Independent prognostic value of somatic TP53 gene mutations in 1794 breast cancer patients

A. Børresen-Dale, J. Bergh, A. Langerød, 2005, Breast Cancer Research.

MYEOV: A candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer

E. Schuuring, C. Bartram, C. Theillet, 2002, International journal of cancer.

Human gp130 transducer chain gene (IL6ST) is localized to chromosome band 5q11 and possesses a pseudogene on chromosome band 17p11.

J. Grosgeorge, C. Theillet, C. Rodríguez, 1995, Cytogenetics and cell genetics.

Software for the integration of multi-omics experiments in Bioconductor

Benjamin Haibe-Kains, David Gomez-Cabrero, Angela Re, 2017, bioRxiv.

DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer Cells

A. Dopazo, J. Benítez, F. Rojo, 2017, Theranostics.

Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol ζ

J. Piette, P. Gourraud, J. Brondello, 2008, Oncogene.